Fluticasone/formoterol BAI

DRUG2 trials

Sponsors

Mundipharma Research Limited

Conditions

Asthma

Phase 1

A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers

CompletedNCT02403713

Mundipharma Research LimitedAsthma

Start: 2014-08-31End: 2015-09-30Target: 125Updated: 2015-09-28

Phase 3

A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma

CompletedNCT02753712

Mundipharma Research LimitedAsthma

Start: 2016-06-15End: 2017-08-14Updated: 2018-10-23